Core Viewpoint - The major shareholder, Phanmao (Shanghai) Investment Center, plans to reduce its stake in Guangdong Derma Technology Co., Ltd. by up to 18,462,500 shares, representing 4% of the total share capital, within three months after the announcement [1][2][3] Shareholder Information - Phanmao (Shanghai) Investment Center holds 87,500,000 shares, accounting for 18.96% of the company's total share capital [1] - The investment center is a private equity fund registered with the Asset Management Association of China [1] Reduction Plan Details - The reason for the reduction is due to the shareholder's personal financial planning [2] - The shares to be reduced are from those acquired before the company's initial public offering and from capital reserves converted into shares post-listing [2] - The reduction will occur through centralized bidding and block trading [3] - The reduction period is set for three months starting fifteen trading days after the announcement [3] - The reduction quantity will be adjusted if there are corporate actions such as stock splits or capital increases [2] Compliance and Commitments - The shareholder has committed to comply with relevant laws and regulations regarding share reduction and has adhered to previous commitments made during the IPO process [4][5] - The shareholder is not in a situation that prohibits share reduction as per the Shenzhen Stock Exchange regulations [4]
德尔玛: 关于持股5%以上股东股份减持计划预披露的公告